| MolName | N-(4-chlorophenyl)-2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]acetamide |
| MolecularFormula | C21H21N3O4Cl2S3 |
| Smiles | O=C(CC(C(N1C2CCCCC2)=O)S/C1=N/S(c(s1)ccc1Cl)(=O)=O)Nc(cc1)ccc1Cl |
| InChI | InChI=1S/C21H21Cl2N3O4S3/c22-13-6-8-14(9-7-13)24-18(27)12-16-20(28)26(15-4-2-1-3-5-15)21(31-16)25-33(29,30)19-11-10-17(23)32-19/h6-11,15-16H,1-5,12H2,(H,24,27)/t16-/m0/s1 |
| InChIK | BKLAJKNLIKXVMD-INIZCTEOSA-N |
| TotalMolweight | 546.519 |
| Molweight | 546.519 |
| MonoisotopicMass | 545.007121 |
| CLogP | 5.3056 |
| CLogS | -6.469 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 366.66 |
| Relative PSA | 0.32463 |
| PolarSurfaceArea | 157.83 |
| Druglikeness | 1.4941 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.51515 |
| Fragments | 1 |
| Non HAtoms | 33 |
| NonCHAtoms | 12 |
| Electronegative Atoms | 12 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 10 |
| Symmetricatoms | 5 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - N-(4-chlorophenyl)-2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]acetamide | 2 - N-(4-chlorophenyl)-2-[(2E)-2-(5-chlorothiophen-2-yl)sulfonylimino-3-cyclohexyl-4-oxo-1,3-thiazolidin-5-yl]acetamide